Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
about
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.
P2860
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@ast
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@en
Vertebral anti-fracture effica ...... o pre-treatment bone turnover.
@nl
type
label
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@ast
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@en
Vertebral anti-fracture effica ...... o pre-treatment bone turnover.
@nl
prefLabel
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@ast
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@en
Vertebral anti-fracture effica ...... o pre-treatment bone turnover.
@nl
P2093
P2860
P1476
Vertebral anti-fracture effica ...... to pre-treatment bone turnover
@en
P2093
D Felsenberg
J Collette
J M Kaufman
J-Y Reginster
M Diaz-Curiel
T D Spector
P2860
P2888
P304
P356
10.1007/S00198-009-0940-Z
P407
P50
P577
2009-05-13T00:00:00Z
P5875
P6179
1026001642